Kirchgraber Paul R - Insider Non-Derivative Transactions at LABCORP HOLDINGS INC. (LH) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 19, 2023, Kirchgraber Paul R's relationship to LABCORP HOLDINGS INC. (LH) is Officer (CEO, Covance Drug Development), and currently has 17,246 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LH insiders.
Data Source: SEC.
Kirchgraber Paul R - Insider Non-Derivative Transactions of LH Common Stock
Kirchgraber Paul R - Insider Non-Derivative Transactions at LH
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 20, 2023 | Sell -- (Common Stock) | 4300 | 216.91 | 12946 |
| May 20, 2023 | M -- (Common Stock) | 4300 | 182.51 | 17246 |
| Mar 31, 2023 | F -- (Common Stock) | 2886 | 224.7 | 12946 |
| Mar 31, 2023 | Acquisition -- (Common Stock) | 6763 | 0 | 15832 |
| Feb 22, 2023 | Sell -- (Common Stock) | 8000 | 250.58 | 9069 |
| Feb 22, 2023 | M -- (Common Stock) | 3000 | 182.51 | 17069 |
| Feb 14, 2023 | F -- (Common Stock) | 142 | 248.13 | 14069 |
| Feb 12, 2023 | M -- (Common Stock) | 483 | 0 | 14211 |
| Feb 7, 2023 | F -- (Common Stock) | 164 | 244.5 | 13728 |
| Feb 5, 2023 | M -- (Common Stock) | 560 | 0 | 13892 |
| Feb 3, 2023 | F -- (Common Stock) | 141 | 254.99 | 13332 |
| Feb 3, 2023 | M -- (Common Stock) | 443 | 0 | 13473 |